Indexové číslo
|
Chemický názov
|
Číslo ES
|
Číslo CAS
|
Klasifikácia
|
Označovanie
|
Špecifické koncentračné limity, M-faktory a ATE
|
Poznámky
|
Kódy tried a kategórií nebezpečnosti
|
Kódy výstražných upozornení
|
Kódy piktogramov a výstražných slov
|
Kódy výstražných upozornení
|
Kódy ďalších výstražných upozornení
|
„007-030-00-3
|
kyselina dusičná …% [C ≤ 70 %]
|
231-714-2
|
7697-37-2
|
Ox. Liq. 3
Acute Tox. 3
Skin Corr. 1A
|
H272
H331
H314
|
GHS03
GHS06
GHS05
Dgr
|
H272
H331
H314
|
EUH071
|
Ox. Liq. 3; H272: C ≥ 65 %
inhalačná: ATE = 2,65 mg/L (pary)
Skin Corr. 1A; H314: C ≥ 20 %
Skin Corr. 1B; H314: 5 % ≤ C < 20 %
|
B“
|
„014-048-00-5
|
vlákna karbidu kremičitého (s priemerom < 3 μm, dĺžkou > 5 μm a pomerom strán ≥ 3:1)
|
206-991-8
|
409-21-2
308076-74-6
|
Carc. 1B
|
H350i
|
GHS08
Dgr
|
H350i“
|
|
|
|
„014-049-00-0
|
trimetoxyvinylsilán; trimetoxy(vinyl)silán
|
220-449-8
|
2768-02-7
|
Skin Sens. 1B
|
H317
|
GHS07
Wng
|
H317“
|
|
|
|
„014-050-00-6
|
tris(2-metoxyetoxy)vinylsilán;
6-(2-metoxyetoxy)-6-vinyl-2,5,7,10-tetraoxa-6-silaundekán
|
213-934-0
|
1067-53-4
|
Repr. 1B
|
H360FD
|
GHS08
Dgr
|
H360FD“
|
|
|
|
„016-098-00-3
|
dimetyldisulfán
|
210-871-0
|
624-92-0
|
Flam. Liq. 2
Acute Tox. 3
Acute Tox. 3
STOT SE 3
STOT SE 1
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H225
H331
H301
H336
H370 (horné dýchacie cesty, inhalácia)
H319
H317
H400
H410
|
GHS02
GHS06
GHS08
GHS09
Dgr
|
H225
H331
H301
H336
H370 (horné dýchacie cesty, inhalácia)
H319
H317
H410
|
|
inhalačná: ATE = 5 mg/L (pary)
orálna: ATE = 190 mg/kg telesnej hmotnosti
M = 1
M = 10“
|
|
„029-024-00-X
|
granulovaná meď;
[dĺžka častíc: od 0,9 mm do 6,0 mm; šírka častíc: od 0,494 do 0,949 mm]
|
231-159-6
|
7440-50-8
|
Aquatic Chronic 2
|
H411
|
GHS09
|
H411“
|
|
|
|
„029-025-00-5
|
bis(N-hydroxy-N-nitrózocyklohexylamináto-O,O’)kuprium;
bis(N-cyklohexyldiazéniumdioxy)meď
[Cu-HDO]
|
239-703-4
|
312600-89-8
15627-09-5
|
Flam. Sol. 1
Acute Tox. 4
STOT RE 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H228
H302
H373 (pečeň)
H318
H400
H410
|
GHS02
GHS07
GHS08
GHS05
GHS09
Dgr
|
H228
H302
H373 (pečeň)
H318
H410
|
|
orálna: ATE = 360 mg/kg telesnej hmotnosti
M = 1
M = 1“
|
|
„050-031-00-9
|
bis(dodekanoyloxy)dioktylstanán; [1]
bis(acyloxy)dioktylstanán“(acyl je z kokosového oleja) [2]
|
222-883-3 [1] 293-901-5 [2]
|
3648-18-8 [1] 91648-39-4 [2]
|
Repr. 1B
STOT RE 1
|
H360D
H372 (imunitný systém)
|
GHS08
Dgr
|
H360D
H372 (imunitný systém)“
|
|
|
|
„601-092-00-0
|
dibenzo[def,p]chryzén;
dibenzo[a,l]pyrén
|
205-886-4
|
191-30-0
|
Carc. 1B
Muta. 2
|
H350
H341
|
GHS08
Dgr
|
H350
H341
|
|
Carc. 1B; H350: C ≥ 0,001 %“
|
|
„603-237-00-3
|
ipkonazol (ISO);
(1RS,2SR,5RS,1RS,2SR,5SR)-2-(4-chlórbenzyl)-5-izopropyl-1-(1H-1,2,4-triazol-1-ylmetyl)cyklopentanol
|
-
|
125225-28-7
115850-69-6
115937-89-8
|
Repr. 1B
Acute Tox. 4
STOT RE 2
Aquatic Chronic 1
|
H360D
H302
H373 (oči, koža, pečeň)
H410
|
GHS08
GHS07
GHS09
Dgr
|
H360D
H302
H373 (oči, koža, pečeň)
H410
|
|
orálna: ATE = 500 mg/kg telesnej hmotnosti
M = 100“
|
|
„603-238-00-9
|
bis(2-(2-metoxyetoxy)etyl)éter; tetraglym
|
205-594-7
|
143-24-8
|
Repr. 1B
|
H360FD
|
GHS08
Dgr
|
H360FD“
|
|
|
|
„603-239-00-4
|
paklobutrazol (ISO);
(2RS,3RS)-1-(4-chlórfenyl)-4,4-dimetyl-2-(1H-1,2,4-triazol-1-yl)pentán-3-ol
|
-
|
76738-62-0
|
Repr. 2
Acute Tox. 4
Acute Tox. 4
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361d
H332
H302
H319
H400
H410
|
GHS08
GHS07
GHS09
Wng
|
H361d
H332
H302
H319
H410
|
|
inhalačná: ATE = 3,13 mg/L (prach alebo hmla)
orálna: ATE = 490 mg/kg telesnej hmotnosti
M = 10
M = 10“
|
|
„603-240-00-X
|
2,2-bis(brómmetyl)propán-1,3-diol
|
221-967-7
|
3296-90-0
|
Carc. 1B
Muta. 1B
|
H350
H340
|
GHS08
Dgr
|
H350
H340“
|
|
|
|
„603-241-00-5
|
geraniol;
(2E)-3,7-dimetylokta-2,6-dién-1-ol
|
203-377-1
|
106-24-1
|
Skin Sens. 1
|
H317
|
GHS07
Wng
|
H317“
|
|
|
|
„605-041-00-3
|
2-(4-terc-butylbenzyl)-propanál
|
201-289-8
|
80-54-6
|
Repr. 1B
|
H360Fd
|
GHS08
Dgr
|
H360Fd“
|
|
|
|
„607-738-00-8
|
MCPA-tioetyl (ISO);
S-etyl-(4-chlór-2-metylfenoxy)etántioát; S-etyl-4-chlór-o-tolyloxytioacetát
|
246-831-4
|
25319-90-8
|
Acute Tox. 4
STOT RE. 2
Aquatic Acute 1 Aquatic Chronic 1
|
H302
H373 (pečeň)
H400
H410
|
GHS07
GHS08
GHS09
Wng
|
H302
H373 (pečeň)
H410
|
|
orálna: ATE = 450 mg/kg telesnej hmotnosti
M = 10
M = 10“
|
|
„607-740-00-9
|
diizooktyl-ftalát
|
248-523-5
|
27554-26-3
|
Repr. 1B
|
H360FD
|
GHS08
Dgr
|
H360FD“
|
|
|
|
„607-741-00-4
|
4-{[(6-chlórpyridín-3-yl)metyl](2,2-difluóretyl)amino}furán-2(5H)-ón; flupyradifurón
|
-
|
951659-40-8
|
Acute Tox. 4
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
|
H302
H373 (svalovina)
H400
H410
|
GHS07
GHS08
GHS09
Wng
|
H302
H373 (svalovina)
H410
|
|
orálna: ATE = 500 mg/kg telesnej hmotnosti
M = 10
M = 10“
|
|
„607-742-00-X
|
tiénkarbazón-metyl (ISO);
O-metyl-4-[(4,5-dihydro-3-metoxy-4-metyl-5-oxo-1H-1,2,4-triazol-1-yl)karbonylsulfamoyl]-5-metyltiofén-3-karboxylát
|
-
|
317815-83-1
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
|
M = 1000
M = 1000“
|
|
„607-743-00-5
|
kyselina (+)-L-mliečna
kyselina (2S)-2-hydroxypropánová
|
201-196-2
|
79-33-4
|
Skin Corr. 1C
Eye Dam. 1
|
H314
H318
|
GHS05
Dgr
|
H314
|
EUH071“
|
|
|
„607-744-00-0
|
2-metoxyetyl-akrylát
|
221-499-3
|
3121-61-7
|
Flam. Liq. 3
Muta. 2
Repr. 1B
Acute Tox. 3
Acute Tox. 4
Skin Corr. 1C
Eye Dam. 1
Skin Sens. 1
|
H226
H341
H360FD
H331
H302
H314
H318
H317
|
GHS02
GHS05
GHS06
GHS08
Dgr
|
H226
H341
H360FD
H331
H302
H314
H317
|
EUH071
|
inhalačná: ATE = 2,7 mg/L (pary)
orálna: ATE = 404 mg/kg telesnej hmotnosti“
|
|
„607-745-00-6
|
kyselina 2-oxoetánová ...%
|
206-058-5
|
298-12-4
|
Eye Dam. 1
Skin Sens. 1B
|
H318
H317
|
GHS05
GHS07
Dgr
|
H318
H317
|
|
|
B“
|
„607-746-00-1
|
nátrium-[(hydroxymetyl)amino]acetát;
formaldehyd uvoľnený z nátrium-[(hydroxymetyl)amino]acetátu]
|
274-357-8
|
70161-44-3
|
Carc. 1B
Muta. 2
Acute Tox. 4
Acute Tox. 4
STOT SE 3
Skin Irrit. 2
Eye Irrit. 2
Skin Sens. 1
|
H350
H341
H332
H302
H335
H315
H319
H317
|
GHS08
GHS07
Dgr
|
H350
H341
H332
H302
H335
H315
H319
H317
|
|
inhalačná: ATE = 3 mg/L (prach alebo hmla)
orálna: ATE = 1100 mg/kg telesnej hmotnosti
|
8
9“
|
„611-181-00-6
|
1-cyklohexyldiazén-1-ium-1,2-bis(olát) draselný;
cyklohexylhydroxydiazén-1-oxid, draselná soľ
[K-HDO]
|
-
|
66603-10-9
|
Flam. Sol. 1
Acute Tox. 3
STOT RE 2
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2
|
H228
H301
H373 (pečeň)
H315
H318
H411
|
GHS02
GHS06
GHS08
GHS05
GHS09
Dgr
|
H228
H301
H373 (pečeň)
H315
H318
H411
|
|
orálna: ATE = 136 mg/kg telesnej hmotnosti“
|
|
„612-294-00-3
|
mecetróniumetylsulfát;
N-etyl-N,N-dimetylhexadekán-1-amónium-etyl-sulfát;
mecetrónium-etylsulfát;
[MES]
|
221-106-5
|
3006-10-8
|
Skin Corr. 1
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H314
H318
H400
H410
|
GHS05
GHS09
Dgr
|
H314
H410
|
EUH071
|
M = 100
M = 1000“
|
|
„613-331-00-6
|
(2RS)-2-[4-(4-chlórfenoxy)-2-(trifluórmetyl)fenyl]-1-(1H-1,2,4-triazol-1-yl)propán-2-ol;
mefentriflukonazol
|
-
|
1417782-03-6
|
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H317
H400
H410
|
GHS07
GHS09
Wng
|
H317
H410
|
|
M = 1
M = 1“
|
|
„613-332-00-1
|
oxatiapiprolín (ISO);
1-(4-{4-[(5RS)-5-(2,6-difluórfenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-tiazol-2-yl}-1-piperidyl)-2-[5-metyl-3-(trifluórmetyl)-1H-pyrazol-1-yl]etanón
|
-
|
1003318-67-9
|
Aquatic Chronic 1
|
H410
|
GHS09
Wng
|
H410
|
|
M = 1“
|
|
„613-333-00-7
|
zinkium-pyritión (T-4)-bis[1-(hydroxy-kO)pyridín-2(1H)-tionáto-kS]zinok
|
236-671-3
|
13463-41-7
|
Repr. 1B
Acute Tox. 2
Acute Tox. 3
STOT RE 1
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H360D
H330
H301
H372
H318
H400
H410
|
GHS08
GHS06
GHS05
GHS09
Dgr
|
H360D
H330
H301
H372
H318
H410
|
|
inhalačná: ATE = 0,14 mg/L (prach alebo hmla)
orálna: ATE = 221 mg/kg telesnej hmotnosti
M = 1000
M = 10“
|
|
„613-334-00-2
|
flurochloridón (ISO);
3-chlór-4-(chlórmetyl)-1-[3-(trifluórmetyl)fenyl]pyrolidín-2-ón
|
262-661-3
|
61213-25-0
|
Repr. 1B
Acute Tox. 4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H360FD
H302
H317
H400
H410
|
GHS08
GHS07
GHS09
Dgr
|
H360FD
H302
H317
H410
|
|
orálna: ATE = 500 mg/kg telesnej hmotnosti
M = 100
M = 100“
|
|
„613-335-00-8
|
4,5-dichlór-2-oktyl-2H-izotiazol-3-ón; [DCOIT]
|
264-843-8
|
64359-81-5
|
Acute Tox. 2
Acute Tox. 4
Skin Corr. 1
Eye Dam. 1
Skin Sens. 1A
Aquatic Acute 1
Aquatic Chronic 1
|
H330
H302
H314
H318
H317
H400
H410
|
GHS06
GHS05
GHS09
Dgr
|
H330
H302
H314
H317
H410
|
EUH071
|
inhalačná: ATE = 0,16 mg/L (prach alebo hmla)
orálna: ATE = 567 mg/kg telesnej hmotnosti
Skin Irrit. 2; H315: 0,025 % ≤ C < 5 %
Eye Irrit. 2; H319: 0,025 % ≤ C < 3 %
Skin Sens. 1A; H317: C ≥ 0,0015 %
M = 100
M = 100“
|
|
„613-336-00-3
|
2-metyl-1,2-benzotiazol-3(2H)-ón;
[MBIT]
|
-
|
2527-66-4
|
Acute Tox. 4
Acute Tox. 3
Skin Corr. 1C
Eye Dam. 1
Skin Sens. 1A
Aquatic Acute 1
Aquatic Chronic 2
|
H312
H301
H314
H318
H317
H400
H411
|
GHS06
GHS05
GHS09
Dgr
|
H312
H301
H314
H317
H410
|
EUH071
|
dermálna: ATE = 1100 mg/kg telesnej hmotnosti
orálna: ATE = 175 mg/kg telesnej hmotnosti
Skin Sens. 1A; H317: C ≥ 0,0015 %
M = 1“
|
|
„616-228-00-4
|
3-(difluórmetyl)-1-metyl-N-(3′,4′,5′-trifluórbifenyl-2-yl)pyrazol-4-karboxamid
fluxapyroxad
|
-
|
907204-31-3
|
Lact.
Aquatic Acute 1
Aquatic Chronic 1
|
H362
H400
H410
|
GHS09
Wng
|
H362
H410
|
|
M = 1
M = 1“
|
|
„616-230-00-5
|
N-(hydroxymetyl)akrylamid metylolakrylamid; [NMA]
|
213-103-2
|
924-42-5
|
Carc. 1B
Muta. 1B
STOT RE 1
|
H350
H340
H372 (periférna nervová sústava)
|
GHS08
Dgr
|
H350
H340
H372 (periférna nervová sústava)“
|
|
|
|
„616-231-00-0
|
5-fluór-1,3-dimetyl-N-[2-4-metylpentán-2-yl]fenyl-1H-pyrazol-4-karboxamid; 2′-[(RS)-1,3-dimetylbutyl]-5-fluór-1,3-dimetylpyrazol-4-karboxanilid;
penflufén
|
-
|
494793-67-8
|
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H351
H400
H410
|
GHS08
GHS09
Wng
|
H351
H410
|
|
M = 1
M = 1“
|
|
„616-232-00-6
|
iprovalikarb (ISO);
izopropyl-[(2S)-3-metyl-1-{[1-(4-metylfenyl)-etyl]-amino}-1-oxobután-2-yl]-karbamát
|
-
|
140923-17-7
|
Carc. 2
|
H351
|
GHS08
Wng
|
H351“
|
|
|
|
„616-233-00-1
|
siltiofam (ISO);
N-alyl-4,5-dimetyl-2-(trimetylsilyl)tiofén-3-karboxamid
|
-
|
175217-20-6
|
STOT RE 2
Aquatic Chronic 2
|
H373
H411
|
GHS08
GHS09
Wng
|
H373
H411“
|
|
|
|
„650-057-00-6
|
Výťažok z melie indickej [za studena lisovaný olej z vylúpaných semien dreviny Azadirachta indica, extrahovaný superkritickým oxidom uhličitým]
|
283-644-7
|
84696-25-3
|
Aquatic Chronic 3
|
H412
|
|
H412“
|
|
|
|